Goodness Growth Holdings to Report Second Quarter Results on August 13, 2021

Rhea-AI Summary

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) will report its financial results for the second quarter ended June 30, 2021, on August 13, 2021, before market opening. A conference call and webcast will occur the same day at 8:00 a.m. ET. Interested parties can register to attend the call via the provided link. Goodness Growth, a physician-led cannabis company, is focused on developing plant-based medicines through its subsidiaries, including Vireo Health. The company operates in eight markets and runs 18 dispensaries across the U.S.

MINNEAPOLIS, July 29, 2021  /PRNewswire/ -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP incubator, today announced that it will report financial results for its second quarter ended June 30, 2021 on Friday, August 13, 2021 before the market opens. 

The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:00 a.m. Eastern Time (7:00 a.m. Central Time). Interested parties may register to attend the call via this link: http://www.directeventreg.com/registration/event/9694714.

Upon registration, each participant will be provided with call details and a registrant ID for Goodness Growth's conference ID number 9694714. A live audio webcast of the call will also be available in the Events & Presentations section of the Company's investor relations website. A webcast replay will be made available for one year on the Company's website.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, and its science and intellectual property incubator, Resurgent Biosciences. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites, and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 18 dispensaries across the United States. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Contact Information

Investor Inquiries:
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com 
(612) 314-8995

Media Inquiries:
Albe Zakes
Vice President, Corporate Communications
albezakes@vireohealth.com  
(267) 221-4800

View original content to download multimedia:https://www.prnewswire.com/news-releases/goodness-growth-holdings-to-report-second-quarter-results-on-august-13-2021-301344063.html

SOURCE Goodness Growth Holdings

FAQ

When will Goodness Growth report its financial results for Q2 2021?

Goodness Growth will report its financial results for the second quarter on August 13, 2021.

What time is the Goodness Growth conference call on August 13, 2021?

The conference call will be held at 8:00 a.m. Eastern Time on August 13, 2021.

How can I register for the Goodness Growth conference call?

Interested parties can register for the conference call via the link provided in the press release.

What is the focus of Goodness Growth Holdings?

Goodness Growth Holdings is a physician-led cannabis company emphasizing the development of plant-based medicines.

How many dispensaries does Goodness Growth operate?

Goodness Growth operates 18 dispensaries across the United States.

In how many markets is Goodness Growth licensed to operate?

Goodness Growth is licensed to operate in eight markets.